III Portfolio Ltd. Vge serves as Executive at Myovant Sciences Ltd., where they oversee executive responsibilities. Since joining the company, III Portfolio Ltd. Vge has executed 8 insider transactions totaling $60.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 19, 2019 involved purchasing 4,957 shares valued at $40.5K.
III Portfolio Ltd. Vge currently holds 22,860,013 shares of Myovant Sciences Ltd. (MYOV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, III Portfolio Ltd. Vge has been a net buyer of MYOV stock. They have purchased $60.3M and sold $0 worth of shares.
III Portfolio Ltd. Vge's most recent insider trade was on Jun 19, 2019, when they purchased 4,957 shares at $8.17 per share.
Get notified when new Form 4 filings are submitted
| $8.21 |
| Discretionary |
| Jun 17, 2019 | UROV | $55.8K | Purchase | 6,541 | $8.53 | Discretionary |
| May 29, 2019 | UROV | $52.0K | Purchase | 6,882 | $7.55 | Discretionary |
| May 28, 2019 | UROV | $29.2K | Purchase | 3,807 | $7.68 | Discretionary |
| May 24, 2019 | UROV | $29.2K | Purchase | 3,796 | $7.70 | Discretionary |
| Oct 1, 2018 | UROV | $37.5M | Purchase | 2,678,571 | $14.00 | Discretionary |
| Apr 2, 2018 | MYOV | $22.5M | Purchase | 1,110,015 | $20.27 | Discretionary |